foxo4-dri senolytic peptide human trial Development of a novel by precise disruption of FOXO4-p53 complex foxo4-dri peptide senolytic human trial

2-page printable handout Prepared by Danielle Alcala-Glazier Wellness Science Series Tirzepatide & Weight Health Dual GIP/GLP-1 pathway education for supervised programs

Key Testing Metrics for Research Peptide Quality Control ISO 17025 Accredited Laboratory Testing To maintain a high level of quality assurance, Frontier Peptide Labs products are tested by an ISO 17025-accredited analytical laboratory

PubChem Reference: View compound profile on NIH PubChem Key Characteristics MOLECULAR PROFILE Formula: C 35 H 48 N 10 O 15 Weight: 848.81 g/mol CAS: 62568-57-4 Structure: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu PHYSICAL PROPERTIES Form: White lyophilized powder Solubility: Water-soluble BBB Penetration: Crosses blood-brain barrier Storage: Keep refrigerated 3646 F (28 C) Related products MOTS-c $60.00 $190.00Price range: $60.00 through $190.00 CJC-1295 $60.00 $95.00Price range: $60.00 through $95.00 NAD+ $40.00 $125.00Price range: $40.00 through $125.00

Hepatocytes absorb copper from portal blood, incorporate it into ceruloplasmin and other cuproproteins, and excrete excess copper through bile [2]